Smooth muscle DNA replication in response to angiotensin II is regulated differently in the neointima and media at different times after balloon injury in the rat carotid artery: Role of AT1 receptor expression

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 9, 1996, Pages 1130-1137

  DeBlois, D ^a,d   Viswanathan, M ^c   Su, J E ^a   Clowes, A W ^b   Saavedra, J M ^c   Schwartz, S M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

angiotensin II receptors; DNA replication; neointima; vascular smooth muscle

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; BROXURIDINE; DNA; RINGER LACTATE SOLUTION;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; ATHEROSCLEROSIS; BALLOON CATHETER; CAROTID ARTERY; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; INTIMA; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR SMOOTH MUSCLE;

EID: 0029763253     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.9.1130     Document Type: Article

References (58)

1. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.
2. Olson NE, Chao S, Lindner V, Reidy MA. Intimal smooth muscle cell proliferation after balloon catheter injury: the role of basic fibroblast growth factor. Am J Pathol. 1992;140:1017-1023.
3. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 1991;68:106-113.
4. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest. 1992;89:507-511.
5. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 1993;13: 1218-1226.
6. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1132.
7. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor beta-1 during repair of arterial injury. J Clin Invest. 1991;88:904-910.
8. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest. 1994;93:1172-1178.
9. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol. 1990;15:S65-S72.
10. Chobanian AV, Haudenschild CC, Nickerson C, Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 1990;15(suppl V):V-65-V-72.
11. Kowala MC. Captopril decreases accelerated atherosclerosis in hypertensive one kidney one clip rats fed cholesterol. Drug Dev Res. 1993;29:100-107.
12. Jacobsson L, Persson K, Aberg G, Andersson RG, Kalberg BE, Olsson AG. Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs, J Cardiovasc Pharmacol. 1994;24:670-677.
13. Kowala MC, Grove RI, Aberg G. Inhibitors of the angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters: fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids. Atherosclerosis. 1994;108:61-72.
14. Clozel J-P, Hess P, Schietinger K, Breu V, Fischli W, Baumgartner HR. Major role of the renin-angiotensin system in the neointima formation after vascular injury. Life Sci. 1994;54:PL87-PL92.
15. Shibutani T, Kanda A, Ishigai Y, Mori T, Chiba K, Tanaka M, Tachizawa H. Inhibitory effect of perindopril, a novel angiotensin-converting enzyme inhibitor, on neointima formation after balloon injury in rats and cholesterol-fed rabbits. J Cardiovasc Pharmacol. 1994;24:509-516.
16. Clozel J-P, Hess P, Michael C, Schietinger K, Baumgartner HR. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs. Hypertension. 1991;18(suppl II): II-55-II-59.
17. Powell J, Clozel J, Muller R, Kuhn H, Hefti F, Hosang M, Baumgartner H. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245: 186-188.
18. Wilcox JN. Thrombin and other potential mechanisms underlying restenosis. Circulation. 1991;84:432-435.
19. Huber KC, Schwartz RS, Edwards WD, Camrud AR, Bailey KR, Jorgenson MA, Holmes DR. Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury model. Am Heart J. 1993;125:695-701.
20. Daemen MJAP, Lombardi DM, Bosman FT, Schwanz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured arterial wall. Circ Res. 1991;68:450-456.
21. Viswanathan M, Stromberg C, Seltzer A, Saavedra JM. Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta. J Clin Invest. 1992;90:1707-1712.
22. Viswanathan M, Seltzer A, Saavedra JM. Heterogeneous expression of angiotensin II AT1 receptors in neointima of carotid artery and aorta after balloon catheter injury. Peptides. 1994;15:1205-1212.
23. Kriss JP, Révész L. The distribution and fate of bromodeoxyuridine and bromodeoxycitidine in the mouse and rat. Cancer Res. 1962; 22:254-265.
24. Van Kleef EM, Smits JFM, DeMey JGR, Cleutjens JPM, Lombardi DM, Schwartz SM, Daemen MJAP. Alpha-1-adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ Res. 1992;70:1122-1127.
25. 125I-brain paste standards for use in quantitative receptor autoradiography. J Neurosci Methods. 1989;30:247-253.
26. Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury, III: endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest. 1986;54:295-303.
27. Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
28. Schwartz SM, Haudenschild CC, Eddy EM. Endothelial regeneration, I: quantitative analysis of initial stages of endothelial regeneration in rat aortic intima. Lab Invest. 1978;38:568-580.
29. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
30. Weber H, Taylor DS, Molloy CJ. Angiotensin II induces delayed autogenesis and cellular proliferation in rat aortic smooth muscle cells. J Clin Invest. 1994;93:788-798.
31. Stouffer GA, Owens GK. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β. Circ Res. 1992;70:820-828.
32. 1 in the cellular growth response to angiotensin II. Hypertension. 1993;21:1046-1050.
33. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 1994;94:978-984.
34. Orlandi A, Ehrlich HP, Ropraz P, Spagnoli LG, Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Anterioscler Thromb. 1994;14:982-989.
35. Lindner V, Reidy MA. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. Circ Res. 1993;73:589-595.
36. Majesky MW, Reidy MA, Bowen-Pope DF, Wilcox JN, Schwartz SM, Platelet-derived growth factor (PDGF) ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111: 2149-2158.
37. Lindner V, Giachelli CM, Schwartz SM, Reidy MA. A subpopulation of smooth muscle cells in injured rat carotid arteries expresses platelet-derived growth factor-B chain mRNA. Circ Res. 1995;76:951-957.
38. Sudhir K, Wilson E, Chatterjee K, Ives HE. Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells. J Clin Invest. 1993;92:3003-3007.
39. Ko Y, Stiebler H, Nickenig G, Wieczorek AJ, Vetter H, Sachinidis A. Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-B on platelet-derived growth factor-BB, basic fibroblast growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. Am J Hypertens. 1993;6:496-499.
40. Kambayashi Y, Bardham S, Inagami T. Peptide growth factors markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;194:478-482.
41. 1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension. 1995;26:752-757.
42. Armstrong ML, Heistad DD, Marcus ML, Megan MB, Piegors DJ. Structural and hemodynamic responses of peripheral arteries of macaque monkeys to atherogenic diet. Arteriosclerosis. 1985; 5:336-346.
43. Shaefer HE. Proliferation versus atrophy: the ambivalent role of smooth muscle cells in human atherosclerosis. Basic Res Cardiol. 1994;89(suppl I):47-58.
44. Clowes AW, Clowes MM. Influence of chronic hypertension on injured and uninjured arteries in spontaneously hypertensive rats. Lab Invest. 1980;43:535-541.
45. deBlois D, Lombardi DM, Su JE, Giachelli CM, Schwartz SM. Vascular expression of osteopontin correlates with DNA synthesis in angiotensin II-mediated hypertension. Hypertension. In press.
46. 1adrenoreceptor stimulation increases DNA synthesis in rat arterial wall: modulation of responsiveness after vascular injury. Arterioscler Thromb Vasc Biol. 1996;16:1122-1129.
47. Van Kleef EM. Angiotensin II and Vascular Growth: The Role of the α1-Adrenoreceptor. Maastricht, Netherlands: Universitaire Pers Maastricht; 1994:1-152.
48. Mulvany MJ, Baandrup U, Gundersen HLG. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional disector. Circ Res. 1985;57:794-800.
49. Owens GK, Schwartz SM. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res. 1983;53:491-501.
50. Cho A, Courtman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 1995;76:168-175.
51. Hamet P, Richard L, Dam T-V, Teiger E, Orlov SN, Gaboury L, Gossard F, Tremblay J. Apoptosis in target organs of hypertension. Hypertension. 1995;26:642-648.
52. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 1995;146:1059-1064.
53. Geng YL, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1 beta-converting enzyme. Am J Pathol. 1995;147:251-266.
54. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
55. Rakugi H, Jacob HJ, Krieger JE, Ingelfinger JR, Pratt RE. Vascular injury induces angiotensinogen gene expression in the media and neointima. Circulation. 1993;87:283-290.
56. Rakugi H, Kim DK, Krieger J, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin-converting enzyme in neointima after balloon injury: possible role in restenosis. J Clin Invest. 1994;94:339-346.
57. Fishel RS, Thourani V, Eisenberg SJ, Shai S-Y, Corson MA, Nabel EG, Bernstein KE, Berk BC. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. J Clin Invest. 1995;95:377-387.
58. Rakugi H, Wang DS, Dzau VJ. Pratt RE. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation. 1994;90:449-455.